Secondary analysis of the phase 3 PACE-B trial in localised prostate cancer: at 5 yr, patient-reported outcomes were comparable for SBRT vs conventional radiotherapy. Pad-free 91% vs 90%; adequate erections 17% vs 20% (from 35% and 40%); bowel problems 5% each.
Secondary analysis
Cooper et al. Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial